We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Refined C-Reactive Protein Cutoffs Help Assess Sepsis Risk in Preterm Babies

By LabMedica International staff writers
Posted on 02 Dec 2025

Early-onset sepsis (EOS) is a dangerous bloodstream infection that appears in the first three days of life, yet its early symptoms resemble many benign newborn conditions. More...

To support urgent treatment decisions, clinicians often turn to C-reactive protein (CRP). While CRP is widely used and has a strong negative predictive value, its optimal cutoffs during the first 72 hours of life have been unclear. A multicenter retrospective study now offers a clearer solution by defining time- and gestation-specific CRP thresholds that help identify which newborns—particularly preterm infants—are most likely to have EOS.

In the study conducted at The Chinese University of Hong Kong (Hong Kong SAR), researchers reviewed electronic health records across all public hospitals to evaluate CRP’s diagnostic performance in more than 100,000 newborns over 11 years. The investigators found that CRP rises naturally after birth in healthy babies, peaking around 24 to 32 hours, and this rise is markedly higher in term infants.

Because of this physiological spike, elevated CRP values early in life may not signal infection in term newborns and can lead to unnecessary antibiotic exposure. In contrast, CRP proved far more reliable in preterm infants. A cutoff above 8.0 mg/L after four hours of life identified infection with strong diagnostic performance among babies born before 34 weeks. For early-onset meningitis, a CRP level greater than 12.0 mg/L showed high specificity and strong negative predictive value, helping rule out disease.

The findings emphasize that CRP should not be interpreted using a universal cutoff for all newborns. Instead, clinicians must account for gestational age, timing of sampling, and the expected physiological rise after birth. Used selectively—especially in preterm infants—CRP can provide meaningful support in EOS screening and help guide when to pursue further testing for meningitis.

“Ours is the first population-based study to evaluate how well CRP testing can identify EOS in newborns, highlighting the fluctuations of CRP levels in a real-world setting,” said Prof. Hugh Simon Lam, who led the research team. “Although CRP isn’t a perfect biomarker for EOS detection, it can still help assess infection risk in preterm babies and guide clinicians on whether further testing for meningitis is needed.”

Related Link
The Chinese University of Hong Kong


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.